The United States Court of Appeals for the Seventh Circuit (“Federal Appellate Court”) overturned a $3 million Illinois state verdict against GlaxoSmithKline LLC (“GSK”), which marketed paroxetine under the Paxil brand name in the United States using the FDA‐approved label… Read More
-
California Supreme Court Holds Brand-Name Drug Manufacturers Can Be Held Liable For Inadequate Labeling By Generic Drug Manufacturers
The deeply-divided Supreme Court of California (“California Supreme Court”) held in its opinion filed on December 21, 2017 that “[b]ecause the same warning label must appear on the brand-name drug as well as its generic bioequivalent, a brand-name drug manufacturer… Read More
